Investor Centre

Investor Centre

Research Firms Analyst E-mail id
Anand Rathi Rashmi Sancheti
Bonanza Alka Katiyar
BP Equities Nikhil Shetty
Centrum Ranjit Kapadia
Dalal & Broacha Charulata Gaidhani
Emkay Jatin Kotian
HDFC Securities . Amey Chalke
IIFL Bhavesh Gandhi
KR Chowksy Hemanshu Srivastava
Motilal Oswal Kumar Saurabh
Motilal Oswal Jehan Bhadha
Nirmal Bang Runjhun Jain
PCS Securities C.Srihari
Spark Capital Harith Ahamed
Systematix Ranvir Singh

Granules India Limited is a vertically integrated Indian pharmaceutical company, based in Hyderabad, India. We manufacture Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs). As Granules stands today, we are organized based on three segments; the Core business which comprises our 'core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the New API business that focuses on manufacturing APIs with a focus on vertical integration and the CRAMS segment, which focuses on contract research and manufacturing.

Granules was incorporated in 1984.

Granules went public by listing its shares in 1995.

Granules is traded on the Bombay Stock Exchange under the code 532482 and National Stock Exchange under the symbol GRANULES.

Please visit Investor Section of the Granules' website to download the latest annual report.

The financial year ends on March 31.

Karvy Computer share Private Limited
Karvy Selenium Tower B, 6th Floor
Plot 31-32, Gachibowli, Financial District.
Nanakramguda, Hyderabad 500 008

Tel: +91-40-67161500

Toll Free No.: 1-800-3454-001;

Fax: +91-40-23001153

Investor Grievance ID: